Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055606614> ?p ?o ?g. }
- W2055606614 endingPage "784" @default.
- W2055606614 startingPage "784" @default.
- W2055606614 abstract "<h3>Importance</h3> <i>Clostridium difficile</i>infection (CDI) is associated with significant morbidity, mortality, and a high risk of recurrence. Proton pump inhibitor (PPI) use is associated with an initial episode of CDI, and PPIs are frequently overprescribed. For many, the use of PPIs could likely be discontinued before CDI recurrence. <h3>Objectives</h3> To determine whether PPI use was associated with a risk of initial CDI recurrence, to assess what proportion of patients who developed CDI were taking a PPI for a non–evidence-based indication, and to evaluate whether physicians discontinued unnecessary PPIs in the context of CDI. <h3>Design, Setting, and Participants</h3> We conducted a retrospective cohort study of incident health care–associated CDI cases to determine the association between continuous PPI use and CDI recurrence within 90 days. The setting was 2 university-affiliated hospitals, the 417-bed Montreal General Hospital (Montreal, Quebec, Canada) and the 517-bed Royal Victoria Hospital (Montreal, Quebec, Canada). The cohort consisted of 754 patients who developed health care–associated CDI between January 1, 2010, and January 30, 2013, and who survived for a minimum of 15 days after their initial episode of nosocomial CDI. <h3>Exposure</h3> Continuous PPI use. <h3>Main Outcomes and Measures</h3> Recurrence of CDI within 15 to 90 days of the initial episode. <h3>Results</h3> Using a multivariable Cox proportional hazards model, the cause-specific hazard ratios for recurrence were 1.5 (95% CI, 1.1-2.0) for age older than 75 years, 1.5 (95% CI, 1.1-2.0) for continuous PPI use, 1.003 (95% CI, 1.002-1.004) per day for length of stay, and 1.3 (95% CI, 0.9-1.7) for antibiotic reexposure. The use of PPIs was common (60.7%), with only 47.1% of patients having an evidence-based indication. Proton pump inhibitors were discontinued in only 3 patients with CDI. <h3>Conclusions and Relevance</h3> After adjustment for other independent predictors of recurrence, patients with continuous PPI use remained at elevated risk of CDI recurrence. We suggest that the cessation of unnecessary PPI use should be considered at the time of CDI diagnosis." @default.
- W2055606614 created "2016-06-24" @default.
- W2055606614 creator A5040595008 @default.
- W2055606614 creator A5056802196 @default.
- W2055606614 creator A5060469865 @default.
- W2055606614 creator A5078477133 @default.
- W2055606614 date "2015-05-01" @default.
- W2055606614 modified "2023-10-16" @default.
- W2055606614 title "Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent<i>Clostridium difficile</i>Infection" @default.
- W2055606614 cites W1914460529 @default.
- W2055606614 cites W1964067924 @default.
- W2055606614 cites W1964383119 @default.
- W2055606614 cites W1986727655 @default.
- W2055606614 cites W1990824360 @default.
- W2055606614 cites W1996461249 @default.
- W2055606614 cites W2007982564 @default.
- W2055606614 cites W2008062441 @default.
- W2055606614 cites W2022124951 @default.
- W2055606614 cites W2030404218 @default.
- W2055606614 cites W2037499366 @default.
- W2055606614 cites W2038981426 @default.
- W2055606614 cites W2047080798 @default.
- W2055606614 cites W2056501325 @default.
- W2055606614 cites W2064266712 @default.
- W2055606614 cites W2070316988 @default.
- W2055606614 cites W2088550873 @default.
- W2055606614 cites W2091320039 @default.
- W2055606614 cites W2098587393 @default.
- W2055606614 cites W2106818996 @default.
- W2055606614 cites W2113556993 @default.
- W2055606614 cites W2130150046 @default.
- W2055606614 cites W2134843796 @default.
- W2055606614 cites W2137723281 @default.
- W2055606614 cites W2139364762 @default.
- W2055606614 cites W2144929147 @default.
- W2055606614 cites W2148171446 @default.
- W2055606614 cites W2150817003 @default.
- W2055606614 cites W2152211277 @default.
- W2055606614 cites W2166660180 @default.
- W2055606614 cites W2171061276 @default.
- W2055606614 cites W2326591042 @default.
- W2055606614 doi "https://doi.org/10.1001/jamainternmed.2015.42" @default.
- W2055606614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25730198" @default.
- W2055606614 hasPublicationYear "2015" @default.
- W2055606614 type Work @default.
- W2055606614 sameAs 2055606614 @default.
- W2055606614 citedByCount "172" @default.
- W2055606614 countsByYear W20556066142015 @default.
- W2055606614 countsByYear W20556066142016 @default.
- W2055606614 countsByYear W20556066142017 @default.
- W2055606614 countsByYear W20556066142018 @default.
- W2055606614 countsByYear W20556066142019 @default.
- W2055606614 countsByYear W20556066142020 @default.
- W2055606614 countsByYear W20556066142021 @default.
- W2055606614 countsByYear W20556066142022 @default.
- W2055606614 countsByYear W20556066142023 @default.
- W2055606614 crossrefType "journal-article" @default.
- W2055606614 hasAuthorship W2055606614A5040595008 @default.
- W2055606614 hasAuthorship W2055606614A5056802196 @default.
- W2055606614 hasAuthorship W2055606614A5060469865 @default.
- W2055606614 hasAuthorship W2055606614A5078477133 @default.
- W2055606614 hasBestOaLocation W20556066141 @default.
- W2055606614 hasConcept C126322002 @default.
- W2055606614 hasConcept C151730666 @default.
- W2055606614 hasConcept C167135981 @default.
- W2055606614 hasConcept C177713679 @default.
- W2055606614 hasConcept C187212893 @default.
- W2055606614 hasConcept C194828623 @default.
- W2055606614 hasConcept C201903717 @default.
- W2055606614 hasConcept C207103383 @default.
- W2055606614 hasConcept C2779343474 @default.
- W2055606614 hasConcept C2781025758 @default.
- W2055606614 hasConcept C2994496256 @default.
- W2055606614 hasConcept C44249647 @default.
- W2055606614 hasConcept C501593827 @default.
- W2055606614 hasConcept C50382708 @default.
- W2055606614 hasConcept C71924100 @default.
- W2055606614 hasConcept C72563966 @default.
- W2055606614 hasConcept C86803240 @default.
- W2055606614 hasConcept C89423630 @default.
- W2055606614 hasConceptScore W2055606614C126322002 @default.
- W2055606614 hasConceptScore W2055606614C151730666 @default.
- W2055606614 hasConceptScore W2055606614C167135981 @default.
- W2055606614 hasConceptScore W2055606614C177713679 @default.
- W2055606614 hasConceptScore W2055606614C187212893 @default.
- W2055606614 hasConceptScore W2055606614C194828623 @default.
- W2055606614 hasConceptScore W2055606614C201903717 @default.
- W2055606614 hasConceptScore W2055606614C207103383 @default.
- W2055606614 hasConceptScore W2055606614C2779343474 @default.
- W2055606614 hasConceptScore W2055606614C2781025758 @default.
- W2055606614 hasConceptScore W2055606614C2994496256 @default.
- W2055606614 hasConceptScore W2055606614C44249647 @default.
- W2055606614 hasConceptScore W2055606614C501593827 @default.
- W2055606614 hasConceptScore W2055606614C50382708 @default.
- W2055606614 hasConceptScore W2055606614C71924100 @default.
- W2055606614 hasConceptScore W2055606614C72563966 @default.
- W2055606614 hasConceptScore W2055606614C86803240 @default.
- W2055606614 hasConceptScore W2055606614C89423630 @default.